Premium Nahrungsergänzungsmittel | artgerecht

Succinyl-CoA – Function in Metabolism

Succinyl-CoA is a key intermediate in the citric acid cycle, playing a central role in energy metabolism and in the biosynthesis of heme and amino acids.

Regular tips about health Regular tips about health

Things worth knowing about "Succinyl-CoA"

Succinyl-CoA is a key intermediate in the citric acid cycle, playing a central role in energy metabolism and in the biosynthesis of heme and amino acids.

What is Succinyl-CoA?

Succinyl-CoA (succinyl-coenzyme A) is a high-energy thioester molecule that serves as a central intermediate in the citric acid cycle (also known as the Krebs cycle or tricarboxylic acid cycle). It is produced by the oxidative decarboxylation of α-ketoglutarate (2-oxoglutarate), a reaction catalyzed by the α-ketoglutarate dehydrogenase complex. Succinyl-CoA functions both as an energy carrier and as a precursor molecule for several important biosynthetic pathways in the body.

Biochemical Function and Mechanism of Action

Within the citric acid cycle, succinyl-CoA is converted to succinate by the enzyme succinyl-CoA synthetase (also called succinate thiokinase). The high-energy thioester bond is used to drive the synthesis of GTP (or ATP in some tissues) from GDP and inorganic phosphate. This reaction is one of the few steps in the citric acid cycle that directly produces a high-energy compound through substrate-level phosphorylation.

The main biochemical roles of succinyl-CoA are:

Citric acid cycle: As the fifth intermediate in the cycle, succinyl-CoA yields energy in the form of GTP upon conversion to succinate.
Heme biosynthesis: Succinyl-CoA condenses with glycine to form δ-aminolevulinic acid (ALA), the committed first step in the synthesis of porphyrins, hemoglobin, and myoglobin.
Amino acid metabolism: Succinyl-CoA is involved in the catabolism of the amino acids methionine, threonine, valine, and isoleucine, which are funneled into the citric acid cycle via propionyl-CoA and methylmalonyl-CoA.
Fatty acid metabolism: Odd-chain fatty acids yield propionyl-CoA upon β-oxidation, which is subsequently converted to succinyl-CoA via methylmalonyl-CoA, allowing entry into the citric acid cycle.
Ketone body metabolism: Succinyl-CoA participates in the utilization of acetoacetate by donating its CoA group, generating acetoacetyl-CoA for energy production.

Formation and Degradation of Succinyl-CoA

Sources of Succinyl-CoA

Succinyl-CoA can be generated in the body through several pathways:

From α-ketoglutarate via the α-ketoglutarate dehydrogenase complex (main route in the citric acid cycle)
From propionyl-CoA via methylmalonyl-CoA, catalyzed by methylmalonyl-CoA mutase (requires vitamin B12)
From the catabolism of specific amino acids (methionine, valine, isoleucine, threonine)
From odd-chain fatty acids via β-oxidation

Vitamin B12 and Methylmalonyl-CoA Mutase

A clinically important aspect of succinyl-CoA metabolism is the dependence of the methylmalonyl-CoA mutase reaction on vitamin B12 (cobalamin). This enzyme requires adenosylcobalamin as a cofactor to convert methylmalonyl-CoA into succinyl-CoA. In cases of vitamin B12 deficiency, this reaction is impaired, leading to the accumulation of methylmalonyl-CoA and methylmalonic acid in the blood and urine. Clinically, vitamin B12 deficiency manifests as megaloblastic anemia and neurological disturbances, partly due to the disruption of this metabolic step.

Clinical Relevance

Succinyl-CoA is not merely a biochemical intermediate; it has direct clinical significance in several conditions:

Porphyrias: Disruptions in heme biosynthesis, which begins with succinyl-CoA and glycine, can lead to porphyrias – a group of rare metabolic disorders characterized by accumulation of porphyrin precursors.
Methylmalonic acidemia (MMA): An inherited deficiency of the methylmalonyl-CoA mutase enzyme blocks the conversion of methylmalonyl-CoA to succinyl-CoA, resulting in the severe metabolic disease methylmalonic acidemia.
Vitamin B12 deficiency: As described, inadequate vitamin B12 impairs succinyl-CoA synthesis and has measurable metabolic and clinical consequences.
Mitochondrial disorders: Diseases affecting mitochondrial function (e.g., mitochondrial myopathies) can impair the citric acid cycle and thereby alter succinyl-CoA metabolism.

Summary

Succinyl-CoA is an indispensable molecule in cellular metabolism. It connects energy production (citric acid cycle), the biosynthesis of vital molecules (heme, porphyrins), and the catabolism of amino acids and fatty acids. Disruptions in its synthesis or utilization can have serious clinical consequences and are associated with well-defined metabolic diseases.

References

Berg, J. M., Tymoczko, J. L., Stryer, L. (2015). Biochemistry. 8th edition. W. H. Freeman and Company.
Devlin, T. M. (2011). Textbook of Biochemistry with Clinical Correlations. 7th edition. Wiley-Liss.
Fowler, B. (2011). Methylmalonic aciduria. In: Physician's Guide to the Diagnosis, Treatment, and Follow-up of Inherited Metabolic Diseases. Springer.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.